Canopy Growth Corporation (CGC) Estados Financieros e Histórico

Canopy Growth Corporation (CGC) — Precio $0.92 HealthcareDrug Manufacturers - Specialty & Generic — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Canopy Growth Corporation (CGC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Canopy Growth Corporation registró ingresos de $284.6M en el último ejercicio fiscal, con un CAGR de 5 años del -12.2%.

Márgenes de los últimos 12 meses: margen bruto 22.9%, margen operativo -46.9%, margen neto -73.9%.

Al precio actual de $0.92, CGC presenta beneficios negativos (P/E no significativo) y un ROE del -29.85%. La capitalización bursátil es de $387M.

Cuenta de Resultados (10 años)

Año2017201820192020202120222023202420252026
Ingresos$39.9M$77.9M$226.3M$398.8M$546.6M$475.7M$333.3M$297.1M$269.0M$284.6M
Coste de Ventas$2.3M$3.8M$137.4M$430.5M$479.7M$663.1M$396.8M$216.3M$189.5M$214.9M
Beneficio Bruto$38.7M$74.2M$88.9M-$31.7M$67.0M-$187.4M-$63.5M$80.9M$79.5M$69.7M
I+D$810000$1.5M$15.2M$61.8M$57.6M$32.3M$21.7M$4.6M00
Generales y Administrativos$38.6M$131.1M$605.8M$867.7M$523.8M$361.1M$298.0M$180.6M$121.7M$122.9M
Gastos Operativos$52.8M$153.1M$642.6M$1.64B$1.31B$831.4M$2.57B$309.6M$196.7M$142.8M
Beneficio Operativo-$14.1M-$107.8M-$615.2M-$1.67B-$1.24B-$1.02B-$2.63B-$228.7M-$117.1M-$73.1M
EBITDA-$650000-$95.7M-$567.1M-$1.38B-$449.7M-$53.0M-$2.88B-$312.8M-$479.3M-$188.2M
Gastos por Intereses$66000$784000$18.4M$6.7M$8.5M$103.9M$126.2M$105.4M$74.6M$38.2M
Beneficio Antes de Impuestos-$10.3M-$51.5M-$709.2M-$1.51B-$1.68B-$267.9M-$3.09B-$471.4M-$597.0M-$262.9M
Impuestos$2.7M-$392000$4.1M-$121.6M-$13.1M-$8.9M-$5.7M$12.3M$7.1M$23000
Beneficio Neto-$7.5M-$67.3M-$736.3M-$1.32B-$1.74B-$310.0M-$3.28B-$657.3M-$598.1M-$262.9M
BPA$-0.14$-0.31$-1.99$-3.96$-4.45$-7.70$-70.70$-8.79$-5.53$-0.88
BPA Diluido$-0.14$-0.31$-1.99$-3.90$-4.45$-7.70$-70.70$-8.79$-5.53$-0.88
Acciones en Circulación (Diluidas)$119.0M$177.3M$337.5M$356.1M$375.7M$39.1M$46.4M$74.8M$107.6M$2.98B

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$66.7M$102.3M$71.2M$81.2M
Beneficio Bruto$21.9M$29.5M$8.3M$22.2M
Beneficio Operativo-$16.9M-$36.2M-$27.5M-$22.1M
EBITDA$16.6M-$63.1M-$137.0M-$4.7M
Beneficio Neto-$1.6M-$85.9M-$157.1M-$14.6M
BPA$-0.01$-0.25$-0.40$-0.03
BPA Diluido$-0.01$-0.25$-0.40$-0.03

Balance (10 años)

Año2017201820192020202120222023202420252026
Caja y Equivalentes$101.8M$322.6M$2.48B$915.6M$1.15B$776.0M$667.7M$170.3M$113.8M$364.7M
Inversiones a Corto00$2.06B$488.2M$1.16B$595.7M$105.5M$33.2M$17.7M$5.1M
Cuentas por Cobrar$5.8M$21.4M$107.0M$63.3M$67.1M$86.6M$68.5M$51.8M$52.8M$36.3M
Inventario$60.7M$118.0M$190.1M$274.8M$369.5M$204.5M$83.2M$77.3M$96.4M$154.1M
Activos Corrientes$178.8M$481.8M$4.92B$1.80B$2.84B$1.73B$1.08B$371.2M$294.6M$529.5M
Inmovilizado Material$96.3M$303.7M$1.10B$1.07B$1.07B$942.8M$471.3M$320.1M$293.5M$441.4M
Fondo de Comercio$241.4M$314.9M$1.54B$1.37B$1.89B$1.87B$85.6M$43.2M$46.0M$77.7M
Activos Intangibles$162.3M$101.5M$519.6M$334.7M$308.2M$252.7M$160.8M$104.1M$87.2M$128.9M
Activos Totales$677.6M$1.44B$8.73B$4.82B$6.82B$5.61B$2.44B$1.30B$917.7M$1.12B
Cuentas por Pagar$5.7M$46.2M$188.9M$86.7M$67.3M$64.3M$31.8M$28.7M$26.1M$34.8M
Deuda a Corto$1.7M$1.6M$103.7M$39.9M$9.8M$9.3M$556.9M$103.9M$4.3M$16.2M
Pasivos Corrientes$17.7M$92.0M$411.7M$295.5M$284.3M$213.2M$803.8M$234.7M$94.4M$158.4M
Deuda a Largo$8.6M$6.9M$842.3M$315.5M$1.57B$1.49B$750.0M$493.3M$299.8M$217.1M
Pasivos Totales$62.9M$193.6M$1.49B$1.18B$3.20B$1.98B$1.68B$799.8M$430.5M$421.1M
Reservas-$21.3M-$91.6M-$835.1M-$3.04B-$6.07B-$6.38B-$9.67B-$10.33B-$10.93B-$11.14B
Patrimonio Neto$639.8M$1.16B$6.78B$3.43B$3.48B$3.58B$758.4M$500.4M$487.2M$697.6M
Deuda Total$10.3M$8.4M$946.0M$439.7M$1.72B$1.64B$1.41B$668.0M$348.4M$278.7M
Deuda Neta-$91.5M-$314.1M-$3.60B-$964.1M-$598.3M$268.5M$640.5M$464.5M$216.9M-$92.0M
Capital Circulante$161.1M$389.7M$4.51B$1.51B$2.55B$1.51B$273.4M$136.5M$200.2M$371.0M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$298.1M$509.5M$364.7M$336.6M
Activos Totales$1.07B$1.52B$1.12B$1.10B
Pasivos Totales$333.8M$477.5M$421.1M$415.3M
Patrimonio Neto$736.0M$1.04B$697.6M$688.6M
Deuda Total$259.3M$350.1M$278.7M$277.3M

Flujo de Caja (10 años)

Año2017201820192020202120222023202420252026
Beneficio Neto-$7.6M-$54.1M-$736.3M-$1.39B-$1.67B-$258.9M-$3.08B-$483.7M-$604.1M-$262.9M
Amortizaciones$6.1M$20.5M$46.9M$125.0M$127.1M$110.9M$80.0M$53.2M$43.1M$36.5M
Compensación en Acciones$10.0M$51.2M$278.2M$320.3M$91.1M$46.7M$25.3M$14.2M-$4.2M$4.3M
Cambio en Capital Circulante-$16.3M-$28.5M-$300.1M-$51.1M$27.7M$205.0M$59.0M$4.0M-$32.0M$20.7M
Flujo de Caja Operativo-$27.1M-$81.5M-$535.0M-$772.6M-$465.7M-$545.8M-$557.5M-$281.9M-$165.8M-$63.8M
Inversiones (CapEx)-$29.5M-$178.1M-$718.8M-$721.9M-$174.1M-$48.1M-$10.5M-$4.0M-$11.3M-$6.0M
Adquisiciones$11.2M-$29.9M-$388.0M-$504.0M$7.0M$103.2M$14.9M-$955000-$7.0M-$41.5M
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$56.6M-$259.6M-$1.25B-$1.49B-$639.9M-$593.9M-$568.0M-$285.9M-$177.0M-$69.8M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$18.0M-$17.2M-$18.3M-$25.0M
Inversiones (CapEx)-$1.5M-$1.9M-$1.1M-$737000
Flujo de Caja Libre-$19.4M-$19.1M-$19.4M-$25.7M
Dividendos Pagados0000
Compensación en Acciones$2.0M$888000$1.5M$1.4M

Crecimiento y Márgenes (10 años)

Año2017201820192020202120222023202420252026
Crecimiento Ingresos (anual)+95.4%+190.4%+76.2%+37.1%-13.0%-29.9%-10.8%-9.5%+5.8%
Crecimiento Beneficio Neto (anual)-794.6%-994.3%-79.5%-32.1%+82.2%-957.3%+80.0%+9.0%+56.0%
Crecimiento BPA (anual)-121.4%-541.9%-99.0%-12.4%-73.0%-818.2%+87.6%+37.1%+84.1%
Cambio en Acciones (anual)+49.0%+90.4%+5.5%+5.5%-89.6%+18.5%+61.3%+43.8%+2671.1%
Crecimiento FCF (anual)-358.5%-383.0%-19.2%+57.2%+7.2%+4.4%+49.7%+38.1%+60.6%
Margen Bruto97.0%95.2%39.3%-7.9%12.2%-39.4%-19.1%27.2%29.6%24.5%
Margen Operativo-35.3%-138.3%-271.8%-418.5%-227.5%-214.2%-789.3%-77.0%-43.5%-25.7%
Margen EBITDA-1.6%-122.8%-250.6%-345.4%-82.3%-11.1%-864.2%-105.3%-178.2%-66.1%
Margen Neto-18.9%-86.3%-325.3%-331.3%-319.2%-65.2%-983.7%-221.2%-222.4%-92.4%
Margen FCF-141.9%-333.0%-554.0%-374.8%-117.1%-124.9%-170.4%-96.2%-65.8%-24.5%
Tasa Impositiva Efectiva-26.3%0.8%-0.6%8.1%0.8%3.3%0.2%-2.6%-1.2%-0.0%

Datos por Acción (10 años)

Año2017201820192020202120222023202420252026
FCF por Acción$-0.48$-1.46$-3.71$-4.20$-1.70$-15.18$-12.25$-3.82$-1.65$-0.02
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$119.0M$177.3M$337.5M$350.0M$375.3M$39.1M$46.4M$74.8M$107.6M$2.98B

Qué mirar en Salud / Farma

El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.

Rentabilidad

Rentabilidad sobre capital-29.85%
Rentabilidad sobre capital invertido-15.31%
Rentabilidad sobre activos-21.43%
Margen bruto22.87%
Margen operativo-46.89%
Margen neto-73.95%

Salud financiera

Deuda / Patrimonio0.40
Ratio corriente3.04

Ratios Clave (10 años)

Año2017201820192020202120222023202420252026
P/E-761.01-1086.67-284.91-51.19-90.42-12.31-0.33-1.16-0.24-1.50
P/VC19.8251.5428.2220.6743.371.031.451.520.295.64
P/V317.77766.24845.46177.94276.227.803.292.560.5213.83
Margen Bruto97.0%95.2%39.3%-7.9%12.2%-39.4%-19.1%27.2%29.6%24.5%
Margen Operativo-35.3%-138.3%-271.8%-418.5%-227.5%-214.2%-789.3%-77.0%-43.5%-25.7%
Margen Neto-18.9%-86.3%-325.3%-331.3%-319.2%-65.2%-983.7%-221.2%-222.4%-92.4%

Empresas relacionadas: ACB · ACRS · BIOA · CABA · DH · IRWD · LFCR

Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic

Más secciones de CGC: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones